Recent Advances in Anti-Infective Drug Discovery
SJR0.304
AE
AEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.304 | Q3 | 43.9% | |
| 2024 | — | — | 0.287 | Q3 | 44.3% | |
| 2023 | — | — | 0.203 | Q3 | 35.7% | |
| 2022 | — | — | 0.277 | Q3 | 48.0% | |
| 2021 | — | — | 0.301 | Q3 | 51.5% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2772-4344
ISSN
2772-4352
country
AEcoverage
2021-2026